li sheng li - Net Worth and Insider Trading
li sheng li Net Worth
The estimated net worth of li sheng li is at least $527,780 dollars as of 2025-01-09. li sheng li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 22,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $527,780. Details can be seen in li sheng li's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that li sheng li has not made any transactions after 2022-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of li sheng li
li sheng li Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, li sheng li owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .
Click here to see the complete history of li sheng li’s form 4 insider trades.
Insider Ownership Summary of li sheng li
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-16 | senior management |
li sheng li Latest Holdings Summary
li sheng li currently owns a total of 1 stock. li sheng li owns 22,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 16, 2022, with a value of $527,780.
Latest Holdings of li sheng li
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-16 | 22,000 | 23.99 | 527,780 |
Holding Weightings of li sheng li
li sheng li Form 4 Trading Tracker
According to the SEC Form 4 filings, li sheng li has made a total of 5 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the acquisition of 100 shares on September 16, 2022, which cost li sheng li around $3,318.
Insider Trading History of li sheng li
- 1
li sheng li Trading Performance
GuruFocus tracks the stock performance after each of li sheng li's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by li sheng li is 13.19%. GuruFocus also compares li sheng li's trading performance to market benchmark return within the same time period. The performance of stocks bought by li sheng li within 3 months outperforms 5 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how li sheng li's insider trading performs compared to the benchmark.
Performance of li sheng li
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.36 | | | | | |
| Relative Return to S&P 500(%) | -0.95 | | | | | |
li sheng li Ownership Network
li sheng li Owned Company Details
What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?
Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?
li sheng li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include Directors & senior managers wen de yong , senior management bao qin gui , and senior management Mei Jing Ping .
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary
Over the past 18 months, li sheng li made no insider transaction in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196). Other recent insider transactions involving Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) include a net sale of 0 shares made by wen de yong , a net sale of 0 shares made by Guan Xiao Hui , and a net sale of 0 shares made by Wu Yi Fang .
In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
li sheng li Mailing Address
Above is the net worth, insider trading, and ownership report for li sheng li. Currently GuruFocus does not have mailing address information for li sheng li.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
